ANAPTYSBIO, INC. Shares Issued
ANAPTYSBIO, INC. (ANAB) had Shares Issued of 29.73 million shares as of 2026-06-30, per its 10-KT filed 2026-09-21.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-09-21
- 2026-06-30: Common Stock, Shares, Issued 29.73M shares.
- 2026-03-31: Common Stock, Shares, Issued 29.03M shares.
- 2025-12-31: Common Stock, Shares, Issued 28.02M shares; Common Stock, Shares, Issued as first filed 28.02M shares.
- 2025-09-30: Common Stock, Shares, Issued 27.58M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 29.73M shares 10-KT · filed 2026-09-21 | |
| 2026-03-31 | 29.03M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 28.02M shares 10-KT · filed 2026-09-21 | 28.02M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 27.58M shares 10-Q · filed 2025-11-04 | |
| 2025-06-30 | 27.97M shares 10-Q · filed 2025-08-06 | |
| 2025-03-31 | 30.39M shares 10-Q · filed 2025-05-05 | |
| 2024-12-31 | 30.47M shares 10-KT · filed 2026-09-21 | 30.47M shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 30.43M shares 10-Q · filed 2024-11-05 | |
| 2024-06-30 | 27.43M shares 10-Q · filed 2024-08-05 | |
| 2024-03-31 | 27.32M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 26.60M shares 10-K · filed 2025-02-27 | 26.60M shares 10-K · filed 2024-03-11 |
| 2023-09-30 | 26.58M shares 10-Q · filed 2023-11-02 | |
| 2023-06-30 | 26.53M shares 10-Q · filed 2023-08-07 | |
| 2023-03-31 | 27.02M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 28.51M shares 10-K · filed 2024-03-11 | 28.51M shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 28.35M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 28.23M shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 28.18M shares 10-Q · filed 2022-05-04 | |
| 2021-12-31 | 27.65M shares 10-K · filed 2023-03-01 | 27.65M shares 10-K · filed 2022-03-07 |
| 2021-09-30 | 27.45M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 27.43M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 27.37M shares 10-Q · filed 2021-05-04 | |
| 2020-12-31 | 27.36M shares 10-K · filed 2022-03-07 | 27.36M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 27.35M shares 10-Q · filed 2020-11-04 | |
| 2020-06-30 | 27.29M shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 27.28M shares 10-Q · filed 2020-05-06 | |
| 2019-12-31 | 27.25M shares 10-K · filed 2021-02-25 | 27.26M shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 27.10M shares 10-Q · filed 2019-11-08 | |
| 2019-06-30 | 27.04M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 27.01M shares 10-Q · filed 2019-05-07 | |
| 2018-12-31 | 26.92M shares 10-K · filed 2020-03-02 | 26.92M shares 10-K · filed 2019-02-28 |
| 2018-09-30 | 26.75M shares 10-Q · filed 2018-11-08 | |
| 2018-06-30 | 24.03M shares 10-Q · filed 2018-08-07 | |
| 2018-03-31 | 23.82M shares 10-Q · filed 2018-05-08 | |
| 2017-12-31 | 23.79M shares 10-K · filed 2019-02-28 | 23.79M shares 10-K · filed 2018-03-05 |
| 2017-09-30 | 20.50M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 20.29M shares 10-Q · filed 2017-08-10 | |
| 2017-03-31 | 20.25M shares 10-Q · filed 2017-05-12 | |
| 2016-12-31 | 2.65M shares 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |